Featuring perspectives from Dr Haley Ellis, Dr Sara Lonardi and Dr Kanwal Raghav, moderated by Dr Christopher Lieu, including the following topics:

• Introduction (0:00)
• Gastroesophageal Cancers — Dr Lonardi (1:54)
• Biliary Tract Cancers — Dr Ellis (39:20)
• Colorectal Cancer — Dr Raghav (1:07:10)

CME information and select publications

Featuring perspectives from Dr Jacqueline Broadway-Duren, Dr Bita Fakhri, Ms Corinne Hoffman and Dr Jeff Sharman, including the following topics:

• Introduction: Key Factors in the Management of Chronic Lymphocytic Leukemia (CLL) (0:00)
• Role of Covalent Bruton Tyrosine Kinase (BTK) Inhibitors for Newly Diagnosed CLL (12:02)
• Role of Time-Limited Up-Front Treatment, Including Therapy Combining BTK Inhibitors and Venetoclax, for Newly Diagnosed CLL (37:55)
• Role of Pirtobrutinib for Relapsed/Refractory (R/R) CLL (1:02:07)
• CAR (Chimeric Antigen Receptor) T-Cell Therapy for R/R CLL (1:16:48)

NCPD information and select publications

Featuring perspectives from Dr Matthew D Galsky, Prof Andrea Necchi and Prof Thomas Powles, moderated by Dr Galsky, including the following topics:

• Introduction (0:00)
• Current and Future Management of Muscle-Invasive Bladder Cancer — Prof Powles (1:14)
• Novel Intravesical Therapies Under Evaluation for Nonmetastatic Urothelial Bladder Cancer (UBC) — Prof Necchi (24:48)
• Selection and Sequencing of Therapy for Metastatic UBC — Dr Galsky (44:52)

CME information and select publications